Verifi NIPT Test
These resources introduce the Verifi and Verifi Plus non-invasive prenatal screening tests, which can be administered from the 10th week of pregnancy.
This podcast episode was prepared with AI assistance. The expressions in the content may occasionally have shortcomings or linguistic errors. The information here is for general informational purposes only; it does not constitute a diagnosis or treatment recommendation. For any evaluation and decision regarding your health condition, please consult your physician or Omega Genetik Diagnostic Evaluation Center.
About the Episode
These resources introduce the Verifi and Verifi Plus non-invasive prenatal screening tests, which can be administered from the 10th week of pregnancy. These tests, performed from a maternal blood sample, use next-generation sequencing technology to identify common chromosomal abnormalities with high accuracy. While the standard Verifi test focuses on basic trisomies and sex chromosomes, the Verifi Plus option offers a broader screening range covering all autosomes and specific microdeletion syndromes. With lower false positive and test failure rates compared to traditional screening methods, these services provide result reports within approximately 3 to 10 days. The texts also emphasize that these tests are not diagnostic and that genetic counseling and confirmatory diagnostic procedures are needed in case of positive results. These documents prepared for physicians detail test indications, performance metrics, and sample patient reports.